Deferred Tax Assets, Valuation Allowance of HAEMONETICS CORP from 02 Apr 2011 to 29 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
HAEMONETICS CORP quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 02 Apr 2011 to 29 Mar 2025.
  • HAEMONETICS CORP Deferred Tax Assets, Valuation Allowance for the quarter ending 29 Mar 2025 was $11,930,000, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

HAEMONETICS CORP Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $11,930,000 +$1,691,000 +17% 29 Mar 2025 10-K 21 May 2025 2025 FY
Q1 2024 $10,239,000 +$1,401,000 +16% 30 Mar 2024 10-K 21 May 2025 2025 FY
Q1 2023 $8,838,000 -$5,239,000 -37% 01 Apr 2023 10-K 20 May 2024 2024 FY
Q1 2022 $14,077,000 +$2,996,000 +27% 02 Apr 2022 10-K 22 May 2023 2023 FY
Q1 2021 $11,081,000 -$3,506,000 -24% 03 Apr 2021 10-K 25 May 2022 2022 FY
Q1 2020 $14,587,000 +$3,265,000 +29% 28 Mar 2020 10-K 26 May 2021 2021 FY
Q1 2019 $11,322,000 +$232,000 +2.1% 30 Mar 2019 10-K 20 May 2020 2020 FY
Q1 2018 $11,090,000 -$14,782,000 -57% 31 Mar 2018 10-K 22 May 2019 2019 FY
Q1 2017 $25,872,000 +$1,575,000 +6.5% 01 Apr 2017 10-K 23 May 2018 2018 FY
Q1 2016 $24,297,000 +$8,270,000 +52% 02 Apr 2016 10-K 24 May 2017 2017 FY
Q1 2015 $16,027,000 +$12,944,000 +420% 28 Mar 2015 10-K 01 Jun 2016 2016 FY
Q1 2014 $3,083,000 +$2,074,000 +206% 29 Mar 2014 10-K 22 May 2015 2015 FY
Q1 2013 $1,009,000 -$560,000 -36% 30 Mar 2013 10-K 22 May 2014 2013 FY
Q1 2012 $1,569,000 -$2,061,000 -57% 31 Mar 2012 10-K 20 May 2013 2012 FY
Q1 2011 $3,630,000 02 Apr 2011 10-K 22 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.